NCT00004156View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

May 31, 1999

Primary Completion Date

June 30, 2008

Conditions
Breast Cancer
Interventions
BIOLOGICAL

MUC1-KLH vaccine/QS21

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00004156 - Vaccine Therapy in Treating Patients With Breast Cancer | Biotech Hunter | Biotech Hunter